Is a complete NSE/AJANTPHARM research report available?

No complete published report is available for nse/AJANTPHARM (NSE/AJANTPHARM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/AJANTPHARM stock profile: metrics, valuation and analysis

Market cap	441.4B
Revenue (ttm)	57.8B
Net income (ttm)	11.3B
EPS (ttm)	₹90.8
Shares out	124.9M
P/E (trailing)	38.9x
P/E (forward)	33.9x
Dividend	₹28.0 (0.81%)
Volume	45,547
Beta	0.22

All NSE/AJANTPHARM indicators

Market & fundamental data

Available fields

237

Groups with data

Currency

INR

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	10,421
Employees Change	793%
Employees Change Percent	8.24
Enterprise value	INR 437.5B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.33
Industry PE Fwd	33.69
Isin	INE031B01049
Last refreshed	2026-09-12
Market cap	INR 441.4B
Price	INR 3,560
Price currency	INR
Rev Per Employee	5,542,817.39x
Sector	Healthcare
Sector PE	47.81
Sector PE Fwd	38.12
Sic	2834
Symbol	nse/AJANTPHARM
Website	https://www.ajantapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.57%
EV Earnings	38.55x
EV/EBIT	31.22x
EV/EBITDA	27.76x
EV/FCF	266.7x
EV/Sales	7.57x
FCF yield	0.37%
Forward P/E	33.87x
P/B ratio	9.75x
P/E ratio	38.91x
P/S ratio	7.64x
PE Ratio10 Y	28.46x
PE Ratio3 Y	35.86x
PE Ratio5 Y	31.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	24.26%
EBITDA Margin	27.07%
FCF margin	3.01%
Gross margin	77.22%
Gross Profit	INR 44.6B
Gross Profit Growth	22.03%
Gross Profit Growth Q	26.43%
Gross Profit Growth3 Y	17.76%
Gross Profit Growth5 Y	14.49%
Net Income	INR 11.3B
Net Income Growth	22.04%
Net Income Growth Q	30.89%
Net Income Growth Qo Q	25.32%
Net Income Growth Quarters	13%
Net Income Growth Years	3%
Net Income Growth3 Y	22.23%
Net Income Growth5 Y	10.79%
Pretax Margin	25.85%
Profit Margin	19.65%
Profit Per Employee	INR 1.1M
Profitable Quarters	INR 49
Profitable Years	22
Roa5y	13.22
Roe5y	22.87
ROIC	25.78
Roic5y	24.72

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	11.73%
Cagr15y	39%
Cagr1y	40.09%
Cagr20y	38.54%
Cagr3y	28.89%
Cagr5y	21.61%
Div CAGR10	20.45%
Div CAGR3	23.31%
Div CAGR5	56.78%
EPS Growth	22.02
EPS Growth Q	30.79
EPS Growth Qo Q	25.21
EPS Growth Quarters	13
EPS Growth Years	3
EPS Growth3 Y	23.07
EPS Growth5 Y	11.73
FCF Growth	-80.46%
FCF Growth3 Y	-35.72%
FCF Growth5 Y	-16.52%
OCF Growth	-54.27%
OCF Growth10 Y	4.96%
OCF Growth3 Y	-12.58%
OCF Growth5 Y	-1.69%
Revenue Growth	20.19x
Revenue Growth Q	24.82x
Revenue Growth Qo Q	14.37x
Revenue Growth Quarters	29x
Revenue Growth Years	7x
Revenue Growth3 Y	14.85x
Revenue Growth5 Y	14.23x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 6.6B
Debt	INR 2.7B
Debt EBITDA	INR 0.17
Debt Equity	INR 0.06
Debt FCF	INR 1.62
Equity	INR 45.3B
Interest Coverage	99.86
Net Cash	INR 4B
Net Cash By Market Cap	INR 0.9
Net Cash Growth	-29.44%
Net Debt EBITDA	INR -0.25
Net Debt Equity	INR -0.09
Net Debt FCF	INR -2.42
Tangible Book Value	INR 44.9B
Tangible Book Value Per Share	INR 359
WACC	5.44

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.01%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 28
Dividend Years	21
Dividend Yield	0.81%
Ex Div Date	2026-08-05
Last Dividend	INR 32
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	203.24%
1Y total return	40.06%
200-day SMA	3,039.5
3Y total return	114.17%
50-day SMA	3,497.2
50-day SMA vs 200-day SMA	50over200
5Y total return	165.98%
All Time High	3,796
All Time High Change	-6.22%
All Time High Date	2026-08-18
All Time Low	1.82
All Time Low Change	195,284.19%
All Time Low Date	2003-03-28
ATR	98.1
Beta	0.22
Beta1y	0.03
Beta2y	0.2
Ch YTD	28.57
High	3,559.9
High52	3,796
High52 Date	2026-08-18
High52ch	-6.22%
Low	3,460
Low52	2,329.9
Low52 Date	2025-09-30
Low52ch	52.79%
Ma50ch	1.79%
Price vs 200-day SMA	17.12%
RSI	50.39
RSI Monthly	70.21
RSI Weekly	63.66
Sharpe ratio	1.24x
Sharpe Ratio3y	0.86x
Sharpe Ratio5y	0.64x
Sortino ratio	2.32
Sortino Ratio3y	1.58
Sortino Ratio5y	1.22
Total Return	0.79%
Tr YTD	29.75
Tr15y	13,868.07%
Tr1m	1.53%
Tr1w	1.1%
Tr3m	16.83%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	42,047,470%
Net Borrowing	1,979,100,000
Shares Insiders	42.19%
Shares Institutions	22.03%
Shares Out	124,935,624
Shares Qo Q	0.08%
Shares Yo Y	0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR 1.6B
Adjusted OCF	5,276,600,000
Average Volume	70,967.75x
Bv Per Share	362.4
CAPEX	INR -3.7B
Ch10y	174.2
Ch15y	12,126.6
Ch1m	1.53
Ch1w	1.1
Ch1y	37.25
Ch20y	51,808.7
Ch3m	15.77
Ch3y	105.6
Ch5y	149.1
Ch6m	18.67
Change	1.13%
Change From Open	1.25
Close	3,520
Days Gap	-0.11
Depreciation Amortization	1,625,975,000
Dollar Volume	162,142,765.3
Earnings Date	2026-10-30
EBIT	INR 14B
EBITDA	INR 15.6B
EPS	INR 90.81
F Score	3
FCF	INR 1.6B
FCF EV Yield	0.37x
FCF Per Share	INR 13.13
Financing CF	-1,679,200,000
Fiscal Year End	March
Founded	1,973
Graham Number	860.43372
Graham Upside	-75.83
Income Tax	INR 3.6B
Investing CF	-4,289,200,000
Is Primary Listing	1
Last Earnings Date	2026-07-30
Last Report Date	2026-06-30
Last Split Date	2022-06-22
Last Split Type	Forward
Lynch Fair Value	INR 980
Lynch Upside	-72.47
Ma150	3,154.1
Ma150ch	12.87%
Ma20	3,573.2
Ma20ch	-0.37%
Net CF	-676,500,000
Next Earnings Date	2026-10-30
Open	3,516
P FCF Ratio	269.1
P FCF Ratio SBC	271.7
P OCF Ratio	83.42
P OCF Ratio SBC	83.66
Payment Date	2026-08-29
Position In Range	100
Price Date	2026-09-11
Price EBITDA	INR 28.23
Ptbv Ratio	9.84
Relative Volume	0.62x
Revenue	57,761,700,000x
SBC By Revenue	0.03x
Share Based Comp	15,300,000
Tax By Revenue	6.21x
Tax Rate	24%
Tr20y	67,730.76%
Tr6m	19.75%
Volume	45,547

NSE/AJANTPHARM (NSE/AJANTPHARM)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/AJANTPHARM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/AJANTPHARM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/AJANTPHARM

Frequently asked questions